Pharmaceutical
Kalydeco : Orphan maintenance assessment report (post-authorisation) (II-0089)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Kalydeco : Orphan maintenance assessment report (post-authorisation) (II-0089)
Strength
Kalydeco : Orphan maintenance assessment report (post-authorisation) (II-0089)
Pack Size
Kalydeco : Orphan maintenance assessment report (post-authorisation) (II-0089)
Form
Kalydeco : Orphan maintenance assessment report (post-authorisation) (II-0089)
Source
European Medicines Agency
Safety Profile
Contraindications
Kalydeco : Orphan maintenance assessment report (post-authorisation) (II-0089)
Side Effects
Kalydeco : Orphan maintenance assessment report (post-authorisation) (II-0089)
Scan this QR code to access this page quickly on your mobile device.